A previously unidentified genetic mutation in a small protein provides significant protection against Parkinson’s disease and offers a new direction for exploring potential treatments, according to a new USC Leonard Davis School of Gerontology study.
Infants born extremely prematurely need to get enrichment as an addition to breast milk. But does it make any difference whether the enrichment is made from breast milk or cow’s milk when it comes to the risk of severe complications in children? This has been investigated by a large clinical study led from Linköping, Sweden.
For people looking to start 2024 with a new routine to feel fitter and happier, a new study from the University of Bath suggests that combining mindfulness with exercise could be your key to success.
A new research paper was published on the cover of Aging, titled “Age-related alterations in the oscillatory dynamics serving verbal working memory processing.”
Cancer arises when multiple mutations result in relentless, inappropriate cell growth. But these mutations don’t act in isolation. Instead, mutations can influence each other in ways that affect cancer evolution. Researchers have long struggled to get a handle on these interactions, often by making assumptions that oversimplify the complex reality.
A new study by researchers at the Case Western Reserve School of Medicine reveals that a chemical used in the diabetes drug Ozempic and the weight-management drug Wegovy is not associated with an increased risk for suicidal thoughts.
In a world grappling with the complexities of mental health conditions like anxiety, depression, and PTSD, new research from Boston University neuroscientist Dr. Steve Ramirez and collaborators offers a unique perspective.
A two-step screening protocol that combines clinical risk assessment with biomarker testing can more effectively identify which patients with type 2 diabetes need medication to prevent heart failure, according to a study led by UT Southwestern Medical Center researchers.
Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease’s significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a recent study has found.
A new artificial intelligence tool that interprets medical images with unprecedented clarity does so in a way that could allow time-strapped clinicians to dedicate their attention to critical aspects of disease diagnosis and image interpretation.